Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
10/03/20169:39AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
10/03/20169:38AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
09/29/20163:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
09/29/20163:01PMBusiness WireImmunoGen Completes Strategic Review to Strengthen the Organization and Drive Long-Term GrowthNASDAQ:IMGNImmunoGen Inc
09/16/20167:38AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
08/25/20163:10PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:IMGNImmunoGen Inc
08/25/20162:36PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
08/17/20167:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
08/09/20167:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
08/09/20167:30AMBusiness WireImmunoGen Announces Departure of Chief Development OfficerNASDAQ:IMGNImmunoGen Inc
08/05/20167:30AMBusiness WireImmunoGen, Inc. Announces Webcasts of Presentations at Upcoming Investor ConferencesNASDAQ:IMGNImmunoGen Inc
08/04/20165:37AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
08/04/20165:30AMBusiness WireImmunoGen Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Provides Quarterly Business UpdateNASDAQ:IMGNImmunoGen Inc
07/21/20162:00PMBusiness WireImmunoGen, Inc. Announces Conference Call to Discuss Its Fourth Quarter and Fiscal Year 2016 Financial ResultsNASDAQ:IMGNImmunoGen Inc
07/20/20163:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/20/20163:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/20/20163:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/20/20163:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/20/20163:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/20/20163:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/20/20163:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/20/20163:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/06/20169:14AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/06/20169:14AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/06/20169:14AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/30/20167:45AMPR Newswire (US)Why Investors Love These Biotech's Stocks? - ImmunoGen, Immunomedics, Vanda Pharma, and Arrowhead PharmaNASDAQ:IMGNImmunoGen Inc
06/20/20164:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
06/15/20167:58AMBusiness WireImmunoGen Announces Pricing of $100 Million Offering of 4.50% Convertible Senior Notes Due 2021NASDAQ:IMGNImmunoGen Inc
06/13/20164:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
06/13/20163:01PMBusiness WireImmunoGen Announces Proposed $100 Million Offering of Convertible Senior Notes Due 2021NASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN